Literature DB >> 12100078

Bone metabolism markers and bone mass in healthy pubertal boys and girls.

S C C M van Coeverden1, J C Netelenbos, C M de Ridder, J C Roos, C Popp-Snijders, H A Delemarre-van de Waal.   

Abstract

OBJECTIVE: During puberty, bone growth and mineralization as well as bone turnover increase dramatically. The relation between height velocity and bone turnover is already known, but there are few studies in which both bone metabolism markers and bone mass throughout puberty have been measured.
DESIGN: Semi-longitudinal study. In 155 healthy boys (12.0 +/- 1.5 years; range 8.8-15.7 years) and 151 healthy girls (11.2 +/- 1.6 years; range 8.2-14.0 years) markers of bone formation and bone resorption were measured as well as sex steroids, IGF-1 and IGF-BP3, together with bone mineral content (BMC) and bone mineral density (BMD) of the lumbar spine, femur and total body during puberty. All bone measurements were repeated after 1 year.
RESULTS: BMC and BMD increased throughout puberty in both sexes. Bone turnover markers increased significantly until maximum values were reached at stage G4 in boys and stage B3 in girls. Height velocity (HV) had a similar changing pattern. Sex steroids and IGF-1 increased and reached adult values at pubertal stage 4. The correlations between bone metabolism markers and BMC were highly significant in boys, while correlations between bone metabolism markers and the increase in BMC over 1 year were significant in both sexes, as was observed for the correlations with HV.
CONCLUSIONS: Our data suggest that bone metabolism markers are good predictors of bone mass in boys and of bone mass increase in both sexes. In early puberty, sex steroids stimulate the pubertal growth spurt in conjunction with GH and IGF-1. The fast increase in height gives rise to an increase in bone turnover and bone mineral apposition. It is known that at the end of puberty high levels of oestradiol inhibit chondrocyte proliferation. This leads to a decline in height velocity and bone turnover. Bone mass still increases under the influence of sex steroids and IGF-1. The data in our study confirm previous reports that markers of bone turnover relate positively to height velocity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100078     DOI: 10.1046/j.1365-2265.2002.01573.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  39 in total

1.  Metabolic bone disease in human immunodeficiency virus-infected children.

Authors:  Stephen Arpadi; Mary Horlick; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

2.  The muscle-bone unit of peripheral and central skeletal sites in children and young adults.

Authors:  R L Ashby; J E Adams; S A Roberts; M Z Mughal; K A Ward
Journal:  Osteoporos Int       Date:  2010-03-24       Impact factor: 4.507

3.  Bone Mineral Content as a Driver of Energy Expenditure in Prepubertal and Early Pubertal Boys.

Authors:  Lynae J Hanks; Orlando M Gutiérrez; Ambika P Ashraf; Krista Casazza
Journal:  J Pediatr       Date:  2015-04-01       Impact factor: 4.406

Review 4.  The endocrine manifestations of anorexia nervosa: mechanisms and management.

Authors:  Melanie Schorr; Karen K Miller
Journal:  Nat Rev Endocrinol       Date:  2016-11-04       Impact factor: 43.330

Review 5.  Gut Microbiota and IGF-1.

Authors:  Jing Yan; Julia F Charles
Journal:  Calcif Tissue Int       Date:  2018-01-23       Impact factor: 4.333

Review 6.  Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.

Authors:  Matthew B Greenblatt; Joy N Tsai; Marc N Wein
Journal:  Clin Chem       Date:  2016-12-09       Impact factor: 8.327

7.  Inhibition of Pref-1 (preadipocyte factor 1) by oestradiol in adolescent girls with anorexia nervosa is associated with improvement in lumbar bone mineral density.

Authors:  Alexander T Faje; Pouneh K Fazeli; Debra Katzman; Karen K Miller; Anne Breggia; Clifford J Rosen; Nara Mendes; Madhusmita Misra; Anne Klibanski
Journal:  Clin Endocrinol (Oxf)       Date:  2013-07-02       Impact factor: 3.478

8.  Prostaglandin E2 and bone turnover markers in the evaluation of primary hypertrophic osteoarthropathy (pachydermoperiostosis): a case report.

Authors:  A Martínez-Ferrer; P Peris; Ll Alós; M Morales-Ruiz; N Guañabens
Journal:  Clin Rheumatol       Date:  2009-05-21       Impact factor: 2.980

9.  Serum alkaline phosphatase reflects post-Fontan hemodynamics in children.

Authors:  Alvin J Chin; P Stephens; E Goldmuntz; M B Leonard
Journal:  Pediatr Cardiol       Date:  2008-08-07       Impact factor: 1.655

10.  The relationships among bone health, insulin-like growth factor-1 and sex hormones in adolescent female athletes.

Authors:  Rita Gruodyte; Jaak Jürimäe; Meeli Saar; Toivo Jürimäe
Journal:  J Bone Miner Metab       Date:  2009-10-15       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.